Levalbuterol has not been established to have therapeutic advantage over racemic albuterol

J Allergy Clin Immunol. 2002 Aug;110(2):325; author reply 325-8. doi: 10.1067/mai.2002.126375.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use*
  • Albuterol / therapeutic use*
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / drug therapy*
  • Asthma / physiopathology
  • Child
  • Consumer Product Safety
  • Dose-Response Relationship, Drug
  • Forced Expiratory Volume
  • Humans

Substances

  • Adrenergic beta-Agonists
  • Anti-Asthmatic Agents
  • Albuterol